4.3 Interaction With U.S. GAAP Disclosure Requirements
While the investment in an equity method investee and its results are generally
reflected in a single line item within the registrant’s balance sheet and income
statement, there are several nuances that financial statement preparers must
consider when determining the appropriate presentation of equity method investments.
ASC 323 outlines additional disclosure requirements that must be evaluated. See
Chapter 6 of Deloitte’s Roadmap Equity Method Investments and Joint Ventures
for discussion of presentation and disclosures.
Rule
4-08(g) requires a registrant to disclose summarized financial
information of equity method investee(s) when the significance of the investee(s) to
the registrant (individually or in the aggregate) exceeds 10 percent. ASC
323-10-50-3(c) requires similar disclosures when an equity method investee is
material. The summarized financial information required by Rule 4-08(g) generally
satisfies the requirements of ASC 323-10-50-3(c). If an equity method investee does
not exceed the 10 percent significance test but is material, the registrant should
provide the information required by ASC 323-10-50-3(c).
However, under SAB Topic
6.K.4(b), the summarized financial information required by Rule
4-08(g) and ASC 323-10-50-3(c) may be omitted if a registrant includes the separate
financial statements of a significant equity method investee when the registrant
files its Form 10-K in accordance with Rule 3-09. In providing relief from the
requirement to present summarized financial information of an equity method
investee, SAB Topic 6.K.4(b) clarifies that the objective of Rule 4-08(g) is to
provide the minimum level of disclosure about a registrant’s investment in an equity
method investee that would be considered relevant to users of the registrant’s
financial statements. When a registrant includes the audited financial statements of
an equity method investee, the registrant has actually provided more than the
minimum level of information and therefore has satisfied the requirements of Rule
4-08(g) and ASC 323 (for more information, see paragraph 2420.5 of the FRM). However, if
the registrant has more than one equity method investee and the aggregate
significance of all equity method investees (including the entity for which separate
financial statements are filed) to the registrant exceeds 10 percent, summarized
financial information under Rule 4-08(g) would be required for the equity method
investees for which separate financial statements are not provided.
In certain circumstances, such as when the registrant and equity
method investee have different fiscal year-ends, the financial statements of the
equity method investee may not be required as of the original due date of the Form
10-K and may be filed in an amendment to the Form 10-K. As explained in paragraph
2420.5 of the FRM, if the separate financial statements of the equity method
investee “are not filed at the same time as the [registrant’s] Form 10-K,” the
guidance in SAB Topic 6.K.4(b) does not apply and “the registrant must include [the]
summarized financial information in its audited financial statements.”
Further, if the separate financial statements of the equity method
investee are not included in the same document or filing as the registrant’s
financial statements, the registrant’s financial statements may not be compliant
with U.S. GAAP (e.g., ASC 323) or SEC rules and regulations (e.g., Rule 4-08(g)) if
the summarized financial information is omitted. For example, this could be the case
in an annual report to shareholders in which the registrant is permitted to omit the
separate financial statements of the equity method investee (for more information,
see the note
to paragraph 2420.5 of the FRM). In this situation, the registrant is required to
include summarized financial information for equity method investees in its
financial statements.
A registrant should carefully consider the circumstances under which it may rely on
the accommodation in SAB Topic 6.K.4(b) to omit the summarized financial information
of an equity method investee that is otherwise required by Rule 4-08(g) and ASC
323-10-50-3(c).